Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Phase II/III Study to Compare the Combination of Carboplatin Plus Irinotecan Vs. the Combination of Carboplatin Plus Etoposide for SCLC in Extensive Disease Stage

NCT00168896 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT00168896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00168896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Phase II/III Study to Compare the Combination of Carboplatin Plus Irinotecan Vs. the Combination of Carboplatin Plus Etoposide for SCLC in Extensive Disease Stage
Lead sponsor
Charite University, Berlin, Germany
Phase
Phase 2/3
Overall status
Unknown status
Start date
October 31, 2001
Completion date
December 31, 2006
Enrollment
286
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung cancer